Cerenovus

So Schlomi just rolled Pulsar Vascular and Neuravi into a new company called Cerenovus. The website said it is part of the Depuy family of companies.

"Our neurovascular business is evolving and Cerenovus reflects our bold new vision, positioning and priorities," group chairman Shlomi Nachman said in prepared remarks. "Inspired by how quickly a stroke can affect a person's mind and our commitment to reducing the devastating impact, Cerenovus aims to help physicians give stroke patients a new lease on life."

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

Any insider willing to share how the business is going?

EMBOTRAP is a great product. That good enough info for you?

post

This is an unproven business, what are you talking about?!

Any insider willing to share how the business is going?

post

This is an unproven business, what are you talking about?!

250k at plan with a car and discounted facewash is proven enough for me. I don't care if it folds after a couple of years because they'll throw a nice severance my way while I'm looking for another job.

post

Cerenovus is actually a good division to be at JNJ. Numbers are solid and division is safe. Can't say that for anyone else on the device side at JNJ.

This is an unproven business, what are you talking about?!

post

Those numbers could be true until you get laid off next January.

Cerenovus is actually a good division to be at JNJ. Numbers are solid and division is safe. Can't say that for anyone else on the device side at JNJ.

post

Could a current rep with Cerenovous confirm these numbers are correct. There is a Sacramento position out there and the internal recruiter is saying 200k-230k with a car. These numbers seem high for a J&J job. The job does sound great though.

Those numbers could be true until you get laid off next January.

post

Putting their money where Schlomi's mouth is by paying the reps so well. Internal recruiters are pitching 70k base and up to 250k at plan with a car. Not many of those jobs going around these days.

Could a current rep with Cerenovous confirm these numbers are correct. There is a Sacramento position out there and the internal recruiter is saying 200k-230k with a car. These numbers seem high for a J&J job. The job does sound great though.

post

Launch party in Cerenovous but layoffs at Depuy. Nothing ever changes at JNJ.

post

Putting their money where Schlomi's mouth is by paying the reps so well. Internal recruiters are pitching 70k base and up to 250k at plan with a car. Not many of those jobs going around these days.

The promises JNJ makes to their reps. Ha...

post

Shlomi said it was growing 90% year over year, and Cerenovus was going to put both Stryker & Medtronic out of business this year.

Putting their money where Schlomi's mouth is by paying the reps so well. Internal recruiters are pitching 70k base and up to 250k at plan with a car. Not many of those jobs going around these days.

post

Cerenovus is one of the fastest growing divisions in JNJ and is in the process of bumping up their sales team.

Shlomi said it was growing 90% year over year, and Cerenovus was going to put both Stryker & Medtronic out of business this year.

post

Cerenovus is one of the fastest growing divisions in JNJ and is in the process of bumping up their sales team.

post

Loading...


Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.